1st Quarter - Report

LOPER CONSULTING LLC for TEVA PHARMACEUTICALS USA

Period 1st Quarter 2012 Filed Apr 10, 2012 Signed by Ginger Loper

Official filing
Firm
LOPER CONSULTING LLC
Client
TEVA PHARMACEUTICALS USA
Income
$51,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA user fee bills (generic drug, prescription drug and biosimilar); drug shortage (S.296 and HR 2245); supply chain safety issues (S. 1584; Drug Safety and Accountability Act of 2011)

LobbyistCovered position, as disclosed
GINGER LOPER Special Assistant to the President (2002-2005)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 296 (112th), H.R. 2245 (112th), S. 1584 (112th)

Labor Issues/Antitrust/Workplace LBR

S. 27 Preserve Access to Generic Drugs; S. 1882 Fair and Immediate Release of Generic Drugs

LobbyistCovered position, as disclosed
GINGER LOPER Special Assistant to the President (2002-2005)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 27 (112th), S. 1882 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.